# MAP3K15

## Overview
MAP3K15 is a gene that encodes the protein mitogen-activated protein kinase kinase kinase 15, a serine/threonine kinase involved in the MAPK signaling pathway. This protein plays a pivotal role in regulating various cellular processes, including proliferation, differentiation, and stress response. As a kinase, MAP3K15 is integral to the phosphorylation cascades that transmit signals within cells, influencing cellular homeostasis and response to environmental stimuli. The gene is expressed in several human tissues, such as the adrenal glands, spleen, kidney, pancreas, and pituitary glands, indicating its involvement in diverse physiological functions (Nag2021Human). MAP3K15's activity has been linked to conditions such as diabetes and hypertension, where it may exert protective effects through its regulatory roles in cell stress and apoptotic pathways (Nag2021Human). Additionally, its involvement in neurodegenerative diseases like Lewy Body Dementia highlights its significance in neuronal health and disease (Bayram2024Genetic).

## Structure
MAP3K15, also known as mitogen-activated protein kinase kinase kinase 15, is a serine/threonine kinase involved in various signaling pathways. The primary structure of MAP3K15 consists of a sequence of amino acids that form the protein's backbone. This sequence is crucial for the protein's function and interactions. The secondary structure of MAP3K15 includes alpha helices and beta sheets, which contribute to the protein's stability and functional conformation.

The tertiary structure of MAP3K15 refers to its overall three-dimensional shape, which is stabilized by interactions such as hydrogen bonds and disulfide bridges. These interactions are essential for maintaining the protein's functional conformation and enabling its role in signaling pathways. MAP3K15 may also exhibit a quaternary structure, involving the assembly of multiple protein subunits, although specific details on this aspect are not provided.

MAP3K15 contains specific domains, such as kinase domains, which are critical for its enzymatic activity. The protein can undergo post-translational modifications, including phosphorylation, which can regulate its activity and interactions. Additionally, splice variant isoforms of MAP3K15 may exist, potentially altering its function or localization within the cell.

## Function
MAP3K15, also known as mitogen-activated protein kinase kinase kinase 15, is a serine/threonine kinase involved in the MAPK signaling pathway, which plays a crucial role in regulating cellular processes such as proliferation, differentiation, and stress response. In healthy human cells, MAP3K15 is primarily expressed in the adrenal glands, spleen, kidney, pancreas, and pituitary glands. Within the pancreas, it is found in islet cell subpopulations, including alpha, beta, and delta cells, suggesting a role in maintaining the function of these endocrine cells (Nag2021Human).

MAP3K15 is implicated in the regulation of cell stress and apoptotic cell death, indicating its involvement in cellular homeostasis and response to stress (Nag2021Human). The gene's activity has been linked to diabetes pathophysiology, as increased MAP3K15 activity may contribute to beta cell loss, a key factor in diabetes development (Nag2021Human). Additionally, MAP3K15's expression in the adrenal glands suggests a potential role in catecholamine biosynthesis or glucocorticoid response, which are critical for stress adaptation and metabolic regulation (Nag2021Human). Overall, MAP3K15's function in healthy cells involves critical pathways that maintain cellular and organismal homeostasis.

## Clinical Significance
Mutations and alterations in the MAP3K15 gene have been associated with several diseases and conditions. In the context of diabetes, rare non-synonymous variants in MAP3K15 are linked to a reduced risk of both Type 1 and Type 2 diabetes. Specifically, protein-truncating variants (PTVs) in MAP3K15 are associated with a 40% reduced risk of diabetes, independent of body mass index, suggesting a protective role against the disease (Nag2021Human). This protective effect is also observed in the FinnGen study, where a specific MAP3K15 PTV is linked to decreased diabetes risk (Nag2021Human).

MAP3K15 is also implicated in hypertension. While animal models suggest a hypertensive phenotype with MAP3K15 knockout, human data indicate a protective effect against hypertension with MAP3K15 PTVs. Hemizygous carriers of these variants show lower systolic blood pressure, although certain missense variants, particularly in South Asian ancestry participants, are associated with increased hypertension risk (Nag2021Human).

In the realm of neurodegenerative diseases, MAP3K15 has been associated with Lewy Body Dementia (LBD) in females, potentially through mechanisms involving neuronal apoptosis and neuroinflammatory responses. This association appears to be independent of its link to diabetes (Bayram2024Genetic).

## Interactions
MAP3K15, also known as ASK3, is involved in various protein interactions within the MAPK signaling pathways. In plants, MAP3K15 is part of a cascade involving GhMAP3K15, GhMKK4, and GhMPK6, which plays a crucial role in regulating drought stress responses. GhMAP3K15 phosphorylates GhMKK4, which subsequently phosphorylates GhMPK6. This cascade is involved in activating GhWRKY59, a transcription factor that binds to the promoter of GhDREB2, thereby regulating drought stress responses in cotton (Lin2021Plant).

In the context of wounding responses, MAP3K15 interacts with MKK3 and MPK2 in Arabidopsis. This interaction is part of a signaling module where MKK3 activates MPK2, and MAP3K15 is one of the clade-III MAP3Ks that can interact with MKK3, as demonstrated through yeast two-hybrid assays (Sözen2019Wounding).

In human cells, MAP3K15 is implicated in stress-induced apoptotic pathways. It is part of the ASK signalosome, which includes proteins like ASK2 (MAP3K6), and is involved in late-phase transcriptional responses following LPS stimulation in macrophages (Daniels2020Dynamic). These interactions highlight MAP3K15's role in both plant and human stress response pathways.


## References


1. (Nag2021Human) Human genetic evidence supports MAP3K15 inhibition as a therapeutic strategy for diabetes. This article has 6 citations.

[2. (Bayram2024Genetic) Ece Bayram, Paolo Reho, Irene Litvan, Jinhui Ding, J. Raphael Gibbs, Clifton L. Dalgard, Bryan J. Traynor, Sonja W. Scholz, and Ruth Chia. Genetic analysis of the x chromosome in people with lewy body dementia nominates new risk loci. npj Parkinson’s Disease, February 2024. URL: http://dx.doi.org/10.1038/s41531-024-00649-7, doi:10.1038/s41531-024-00649-7. This article has 0 citations.](https://doi.org/10.1038/s41531-024-00649-7)

3. (Sözen2019Wounding) Wounding and insect feeding trigger two independent MAPK pathways with distinct regulation and kinetics. This article has 0 citations.

[4. (Lin2021Plant) Li Lin, Jian Wu, Mingyi Jiang, and Youping Wang. Plant mitogen-activated protein kinase cascades in environmental stresses. International Journal of Molecular Sciences, 22(4):1543, February 2021. URL: http://dx.doi.org/10.3390/ijms22041543, doi:10.3390/ijms22041543. This article has 78 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms22041543)

[5. (Daniels2020Dynamic) Casey M. Daniels, Pauline R. Kaplan, Isaac Bishof, Clinton Bradfield, Trisha Tucholski, Arthur G. Nuccio, Nathan P. Manes, Samuel Katz, Iain D. C. Fraser, and Aleksandra Nita-Lazar. Dynamic adp-ribosylome, phosphoproteome, and interactome in lps-activated macrophages. Journal of Proteome Research, 19(9):3716–3731, June 2020. URL: http://dx.doi.org/10.1021/acs.jproteome.0c00261, doi:10.1021/acs.jproteome.0c00261. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/acs.jproteome.0c00261)